Skip to content
← All treatment topics

TREATMENT READING

Parathyroid Cancer

Source sections for this topic, with the original link and date. Patient and professional reading are labelled separately.

Not medical advice · Not a complete treatment or trial directory

Made by Triangle.

Selected text from the National Cancer Institute, with the original link and date. Made by Triangle. This page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.

Health professional · General Information About Parathyroid Cancer

Clinical Treatment and Management

Source: Parathyroid Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: July 5, 2024. Captured 2026-09-09.

The medical management of hypercalcemia, particularly in patients with unresectable disease or without measurable disease, is critical and must be the initial treatment goal in all patients with HPT. Conventional treatment with intravenous fluids, diuretics, and antiresorptive agents such as bisphosphonates, gallium, or mithramycin may help control the hypercalcemia.[12] Calcimimetic agents that directly block secretion of the parathyroid hormone from the glands may offer an important approach to medical therapy of primary HPT associated with parathyroid cancer.[19,20]

Sources: 12 · 19 · 20

Surgery is the only effective therapy for parathyroid carcinoma.[1,5,6] Preoperative suspicion and intraoperative recognition of parathyroid carcinoma is critical to achieve a favorable outcome, which involves en bloc resection of the tumor with all potential areas of invasion at the initial operation.[12,21,22]

Sources: 1 · 5 · 6 · 12 · 21 · 22

One analysis of the literature indicated a local recurrence rate of 8% after an en bloc resection and 51% after a standard parathyroidectomy.[23] En bloc excision during the initial procedure for parathyroid cancer may involve resection of the recurrent laryngeal nerve because the nerve is at risk for invasion by any residual tumor and subsequent loss of function. The increased potential for long-term local control achieved by en bloc excision outweighs the complication of postoperative vocal cord paralysis, which can be improved with techniques such as Teflon injection into the paralyzed cord. Cervical lymph node dissection should be performed only for enlarged or firm nodes, particularly those found in the level VI paratracheal nodes and levels III and IV internal jugular nodes.[1]

Sources: 23 · 1

Because of the fairly indolent biology of this cancer, the management of recurrent or metastatic disease is primarily surgical. Significant palliation may result from the resection of even very small tumor deposits in the neck, lymph nodes, lungs, or liver.[2,13,16,24,25] Accessible distant metastases should be resected when possible.[5] Localization studies performed before the first operation or reoperation may include technetium Tc 99m-sestamibi (MIBI) scan, single photon emission computed tomography, computed tomography (CT)-MIBI image fusion, ultrasound, CT, selective angiogram, and selective venous sampling for PTH.[3] CT and magnetic resonance imaging are useful imaging adjuncts for the localization of distant metastases.[5,26]

Sources: 2 · 13 · 16 · 24 · 25 · 5 · 3 · 5 · 26

Nonsurgical forms of therapy for parathyroid carcinoma generally have poor results.[1,5,6,11] Some investigators have advocated the use of adjuvant radiation therapy to decrease the local recurrence rate.[27,28] Patients with this disease should be monitored for life because they may be at a relatively high risk of multiple relapses over prolonged periods of time.[11] Patients rarely die of the tumor itself; rather, they die of the metabolic complications of uncontrolled HPT.

Sources: 1 · 5 · 6 · 11 · 27 · 28 · 11

This page is made by Triangle. The reading above is selected source text, not a treatment recommendation, and it is not medical advice.

Health professional

Treatment Option Overview for Parathyroid Cancer

Source: Parathyroid Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: July 5, 2024. Captured 2026-09-09.

The rarity of this tumor does not allow for large published series of treatment experience or permit the systematic evaluation of combination therapies.[1,2] The relatively slow cell-doubling time for this tumor makes radical surgery a therapeutic option even for patients with metastatic disease. Treatment and control of secondary hypercalcemia must be the initial treatment goal in all patients with hyperparathyroidism.

Sources: 1 · 2

Health professional

Treatment of Localized Parathyroid Cancer

Source: Parathyroid Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: July 5, 2024. Captured 2026-09-09.

Treatment options for localized parathyroid cancer include the following:[1-4]

Sources: 1 · 4

The initial operation should include an en bloc resection of the tumor that takes care to avoid rupture of the tumor capsule and to ensure that the margins are free of tumor. This procedure will involve a parathyroidectomy, typically an ipsilateral thyroidectomy (thyroid lobectomy), and possibly resection of adjacent cervical muscles, paratracheal tissues, and the recurrent laryngeal nerve, if involved. Lymphadenectomy, beyond that necessary to achieve an en bloc excision of the primary malignancy, is not indicated unless enlarged or firm nodes clinically indicate the presence of nodal disease. Local recurrence may be minimized by this en bloc resection approach. Preoperative medical management to lower elevated calcium levels and to correct other metabolic disturbances that are due to hyperparathyroidism is critical.

Surgery followed by radiation therapy.[4-6]

Sources: 4 · 6

Radiation therapy.

Health professional

Treatment of Metastatic Parathyroid Cancer

Source: Parathyroid Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: July 5, 2024. Captured 2026-09-09.

Metastatic disease can appear shortly after the initial diagnosis and operation or for up to 20 years later.[1] Because of the difficulty in making a histological diagnosis, the appearance of recurrent or metastatic disease in a patient previously operated on for hypercalcemia can be the first indicator that the tumor was malignant.[2] Approximately 50% of patients who experience recurrence will have distant metastases.[3] The most common site of distant metastasis is the lung.[4,5] Some patients experience years of survival even after the diagnosis of distant metastases.[5] Aggressive surgical resection has been associated with a 30% long-term survival rate in retrospective series.[3,6]

Sources: 1 · 2 · 3 · 4 · 5 · 5 · 3 · 6

Treatment options for metastatic parathyroid cancer include the following:[1,3-10]

Sources: 1 · 3 · 10

Metastasectomy: Because parathyroid carcinoma can be slow-growing, resection of distant metastases can be effective for palliation and occasional cure.

Medical management of hypercalcemia.[5,10-12]

Sources: 5 · 10 · 12

Surgery plus radiation therapy.

Radiation therapy.

Chemotherapy. Anecdotal reports show that short-term remissions with chemotherapy are possible.[5,10]

Sources: 5 · 10

Health professional

Treatment of Recurrent Parathyroid Cancer

Source: Parathyroid Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: July 5, 2024. Captured 2026-09-09.

Approximately 40% to 60% of patients experience a postsurgical recurrence, typically between 2 to 5 years after the initial resection.[1,2] Because it is difficult to establish a histological diagnosis of parathyroid cancer at the time of initial surgery, the appearance of recurrent or metastatic tumor can be the first sign of malignancy.[3]

Sources: 1 · 2 · 3

Because these tumors are slow-growing, repeated resection of local recurrences and/or distant metastases can result in significant palliation.[4-8] Pulmonary metastases and bone metastases should be resected, if possible, to decrease the magnitude of the hypercalcemia.[7,9] Occasionally, long-term salvage is achieved in this group of patients with aggressive surgical treatment.[10] The major morbidity of recurrent or metastatic parathyroid cancer results from severe hypercalcemia, which can be difficult to control. For patients not fit for surgery, treatment with bisphosphonates, plicamycin, calcitonin, and gallium pamidronate may control hypercalcemia.[11] Control of malignant hypercalcemia with these medical measures is often only temporary.

Sources: 4 · 8 · 7 · 9 · 10 · 11

Treatment options for recurrent parathyroid cancer include the following:[4-10]

Sources: 4 · 10

Surgical removal of the local recurrence with surgical removal of metastases when possible. Because parathyroid carcinoma can be slow-growing, resection of local recurrences or distant metastases can bring effective palliation but can rarely cure. Debulking of functional carcinomas may help reduce parathormone production.

Medical management of hypercalcemia.[11,10,12,13]

Sources: 11 · 10 · 12 · 13

Surgery plus radiation therapy.

Radiation therapy.

Chemotherapy. Anecdotal reports show that short-term remissions with chemotherapy are possible.[10,11]

Sources: 10 · 11

For patients · General Information About Parathyroid Cancer

Certain factors affect prognosis (chance of recovery) and treatment options.

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

The prognosis and treatment options depend on:

Sources: prognosis

Whether the calcium level in the blood can be controlled.

The stage of the cancer.

Sources: stage

Whether the tumor and the capsule around the tumor can be completely removed by surgery.

Sources: capsule · surgery

The patient's general health.

For patients · Stages of Parathyroid Cancer

Parathyroid cancer can recur (come back) after it has been treated.

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

The cancer may come back in the tissues or lymph nodes of the neck or in other parts of the body. More than half of patients have a recurrence. The parathyroid cancer usually recurs between 2 and 5 years after the first surgery, but can recur up to 20 years later. It usually comes back in the tissues or lymph nodes of the neck. High blood calcium levels that appear after treatment may be the first sign of recurrence.

Sources: surgery · tissues · lymph nodes · blood · calcium · sign

For patients

Treatment Option Overview

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

For patients · Treatment Option Overview

Key Points

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

There are different types of treatment for patients with parathyroid cancer.

Treatment includes control of hypercalcemia (too much calcium in the blood) in patients who have an overactive parathyroid gland.

The following types of treatment are used:

The following types of treatment are used:

Surgery

Radiation therapy

Chemotherapy

Supportive care

New types of treatment are being tested in clinical trials.

Treatment for parathyroid cancer may cause side effects.

Follow-up care may be needed.

For patients · Treatment Option Overview

There are different types of treatment for patients with parathyroid cancer.

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

Different types of treatment are available for patients with parathyroid cancer. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.

Sources: parathyroid cancer · standard · clinical trials · research study · cancer

For patients · Treatment Option Overview

Treatment includes control of hypercalcemia (too much calcium in the blood) in patients who have an overactive parathyroid gland.

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

In order to reduce the amount of parathyroid hormone that is being made and control the level of calcium in the blood, as much of the tumor as possible is removed in surgery. For patients who cannot have surgery, medication may be used.

Sources: parathyroid hormone · calcium · blood · tumor · surgery · medication

For patients · Treatment Option Overview

The following types of treatment are used:

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

For patients · Treatment Option Overview / The following types of treatment are used:

Surgery

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

Surgery (removing the cancer in an operation) is the most common treatment for parathyroid cancer that is in the parathyroid glands or has spread to other parts of the body. Because parathyroid cancer grows very slowly, cancer that has spread to other parts of the body may be removed by surgery in order to cure the patient or control the effects of the disease for a long time. Before surgery, treatment is given to control hypercalcemia.

Sources: parathyroid glands · cure · hypercalcemia

The following surgical procedures may be used:

En bloc resection: Surgery to remove the entire parathyroid gland and the capsule around it. Sometimes lymph nodes, half of the thyroid gland on the same side of the body as the cancer, and muscles, tissues, and a nerve in the neck are also removed.

Sources: resection · capsule · lymph nodes · thyroid gland · tissues · nerve

Tumor debulking: A surgical procedure in which as much of the tumor as possible is removed. Some tumors cannot be completely removed.

Sources: Tumor debulking

Metastasectomy: Surgery to remove any cancer that has spread to distant organs such as the lung.

Sources: Metastasectomy · organs · lung

Surgery for parathyroid cancer sometimes damages nerves of the vocal cords. There are treatments to help with speech problems caused by this nerve damage.

Sources: vocal cords

For patients · Treatment Option Overview / The following types of treatment are used:

Radiation therapy

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:

Sources: Radiation therapy · x-rays · radiation · cells

External radiation therapy uses a machine outside the body to send radiation toward the area of the body with cancer.

Sources: External radiation therapy

Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.

Sources: Internal radiation therapy · radioactive · seeds · catheters

The way the radiation therapy is given depends on the type and stage of the cancer being treated. External radiation therapy is used to treat parathyroid cancer.

Sources: stage

For patients · Treatment Option Overview / The following types of treatment are used:

Chemotherapy

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). The way the chemotherapy is given depends on the type and stage of the cancer being treated.

Sources: Chemotherapy · drugs · injected · vein · systemic chemotherapy · cerebrospinal fluid · cavity · abdomen · regional chemotherapy

For patients · Treatment Option Overview / The following types of treatment are used:

Supportive care

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

Supportive care is given to lessen the problems caused by the disease or its treatment. Supportive care for caused by parathyroid cancer may include:

Sources: Supportive care

Intravenous (IV) fluids.

Sources: Intravenous · fluids

Drugs that increase how much urine the body makes.

Sources: urine

Drugs that stop the body from absorbing calcium from the food we eat.

Drugs that stop the parathyroid gland from making parathyroid hormone.

For patients · Treatment Option Overview

New types of treatment are being tested in clinical trials.

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

For some people, joining a clinical trial may be an option. There are different types of clinical trials for people with cancer. For example, a treatment trial tests new treatments or new ways of using current treatments. Supportive care and palliative care trials look at ways to improve quality of life, especially for those who have side effects from cancer and its treatment.

You can use the clinical trial search to find NCI-supported cancer clinical trials accepting participants. The search allows you to filter trials based on the type of cancer, your age, and where the trials are being done. Clinical trials supported by other organizations can be found on the ClinicalTrials.gov website.

Sources: clinical trial search · ClinicalTrials.gov

Learn more about clinical trials, including how to find and join one, at Clinical Trials Information for Patients and Caregivers.

Sources: Clinical Trials Information for Patients and Caregivers

For patients · Treatment Option Overview

Treatment for parathyroid cancer may cause side effects.

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

For information about side effects caused by treatment for cancer, visit our Side Effects page.

Sources: side effects · Side Effects

For patients · Treatment Option Overview

Follow-up care may be needed.

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

As you go through treatment, you will have follow-up tests or check-ups. Some tests that were done to diagnose or stage the cancer may be repeated to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.

Sources: diagnose · stage

Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back).

Parathyroid cancer often recurs. Patients should have regular check-ups for the rest of their lives, to find and treat recurrences early.

Sources: recurs

For patients

Treatment of Localized Parathyroid Cancer

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

Treatment of localized parathyroid cancer may include:

Sources: localized · parathyroid cancer

Surgery (en bloc resection).

Sources: Surgery · resection

Surgery followed by radiation therapy.

Sources: radiation therapy

Radiation therapy.

Supportive care to treat (too much calcium in the blood).

Sources: Supportive care · Source reference · calcium · blood

Learn more about these treatments in the Treatment Option Overview.

Sources: Treatment Option Overview

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

For patients

Treatment of Metastatic Parathyroid Cancer

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

Treatment of metastatic parathyroid cancer may include:

Sources: metastatic · parathyroid cancer

Surgery (metastasectomy) to remove cancer from the places where it has spread.

Sources: Surgery · metastasectomy · cancer

Surgery followed by radiation therapy.

Sources: radiation therapy

Radiation therapy.

Chemotherapy.

Sources: Chemotherapy

Supportive care to treat hypercalcemia (too much calcium in the blood).

Sources: Supportive care · hypercalcemia · calcium · blood

Learn more about these treatments in the Treatment Option Overview.

Sources: Treatment Option Overview

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

For patients

Treatment of Recurrent Parathyroid Cancer

Source: Parathyroid Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: March 7, 2025. Captured 2026-09-09.

Treatment of recurrent parathyroid cancer may include:

Sources: recurrent · parathyroid cancer

Surgery (metastasectomy) to remove cancer from the places where it has recurred.

Sources: Surgery · metastasectomy · cancer · recurred

Surgery (tumor debulking).

Sources: tumor debulking

Surgery followed by radiation therapy.

Sources: radiation therapy

Radiation therapy.

Chemotherapy.

Sources: Chemotherapy

Supportive care to treat hypercalcemia (too much calcium in the blood).

Sources: Supportive care · hypercalcemia · calcium · blood

Learn more about these treatments in the Treatment Option Overview.

Sources: Treatment Option Overview

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

Sources: clinical trial search · General information

Studies

One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation Study

NCT00580788 · COMPLETED · early phase1

Osteoporosis, Humoral Hypercalcemia of Malignancy, Hyperparathyroidism

ClinicalTrials.gov record

Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands

NCT01273597 · COMPLETED · Phase not reported

Kidney Failure, Chronic

ClinicalTrials.gov record

High Intensity Focused Ultrasound (HIFU) for Parathyroid Adenoma

NCT01291498 · TERMINATED · na

Parathyroid Adenomas

ClinicalTrials.gov record

Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.

NCT03027557 · COMPLETED · phase3

Primary Hyperparathyroidism, Parathyroid Adenoma, Parathyroid Hyperplasia

ClinicalTrials.gov record

Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

NCT03280264 · COMPLETED · phase3

Parathyroid Carcinoma, Primary Hyperparathyroidism

ClinicalTrials.gov record

Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During Parathyroidectomy

NCT04299425 · COMPLETED · na

Parathyroid Adenoma, Parathyroid Neoplasms, Parathyroid Hyperplasia, Parathyroid Cancer, Hypercalcemia, Primary Hyperparathyroidism

ClinicalTrials.gov record

Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

NCT05022641 · COMPLETED · na

Parathyroid Adenoma, Parathyroid Neoplasms, Parathyroid Cancer, Hypercalcemia, Primary Hyperparathyroidism

ClinicalTrials.gov record

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

NCT05022667 · COMPLETED · na

Thyroid Neoplasms, Thyroid Diseases, Hypoparathyroidism, Endocrine System Diseases, Endocrine Gland Neoplasms, Neoplasms by Site, Neoplasms, Head and Neck Neoplasms,...

ClinicalTrials.gov record

Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

NCT05152927 · COMPLETED · na

Parathyroid Diseases, Parathyroid Dysfunction, Parathyroid Neoplasms, Parathyroid Adenoma, Hypercalcemia, Neoplasms, Glandular and Epithelial, Endocrine Gland Neoplasms,...

ClinicalTrials.gov record

Disease and treatment settings

localized Parathyroid Cancer

Disease and treatment setting

Treatment of Localized Parathyroid Cancer

metastatic Parathyroid Cancer

Disease and treatment setting

Treatment of Metastatic Parathyroid Cancer

Parathyroid Cancer

Disease and treatment setting

Parathyroid Cancer

recurrent Parathyroid Cancer

Disease and treatment setting

Treatment of Recurrent Parathyroid Cancer

Drug labels

PARSABIV

Label date 2026-03-08

PARSABIV is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis. PARSABIV is a calcium-sensing receptor agonist indicated for: Secondary...

DailyMed label

Sensipar

Label date 2025-12-07

Sensipar is a positive modulator of the calcium sensing receptor indicated for: Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. ( 1.1 ) Limitations of Use: Sensipar is not indicated...

DailyMed label